Search results for "Agoni"

showing 10 items of 2493 documents

Beta-MSH inhibits brain inflammation via MC(3)/(4) receptors and impaired NF-kappaB signaling.

2005

The anti-inflammatory effects of melanocortin peptides have been demonstrated in different inflammation models. This is the first report describing the molecular mechanisms for the beta-MSH-induced suppression of bacterial lipopolisaccharide (LPS)-caused brain inflammation. We found that beta-MSH suppresses LPS-induced nuclear translocation of the transcription factor NF-kappaB, and inhibits the expression of inducible nitric oxide synthase, and the following nitric oxide overproduction in the brain, in vivo. Moreover, administering the preferentially MC(4) receptor selective antagonist HS014 blocked completely these effects, suggesting a tentative MC(4) receptor mediated mechanism of actio…

LipopolysaccharidesMalemedicine.medical_specialtyImmunologyNitric Oxide Synthase Type IIInflammationElectrophoretic Mobility Shift AssayNitric OxidePeptides CyclicNitric oxidechemistry.chemical_compoundMiceInternal medicinebeta-MSHmedicineImmunology and AllergyAnimalsDrug InteractionsReceptorBrain ChemistryMice Inbred ICRbiologyDose-Response Relationship DrugImmunochemistryElectron Spin Resonance SpectroscopyNF-kappa BNF-κBHormonesCell biologyNitric oxide synthaseDisease Models AnimalEndocrinologyNeurologyMechanism of actionchemistrybiology.proteinEncephalitisReceptor Melanocortin Type 4Neurology (clinical)medicine.symptomMelanocortinSignal transductionhormones hormone substitutes and hormone antagonistsReceptor Melanocortin Type 3Signal TransductionJournal of neuroimmunology
researchProduct

Expression and function of the non-neuronal cholinergic system in endothelial cells

2003

Increasing evidence has shown the expression of the non-neuronal cholinergic system in endothelial cells. In the present experiments the expression of choline acetyltransferase (ChAT) was investigated in human endothelial cells by anti-ChAT immunohistochemistry and anti-ChAT immunofluorescence. Positive ChAT immunoreactivity was found in cultures of human umbilical endothelial cells (HUVEC) and a human angiosarcoma cell line (HAEND). In HUVEC and HAEND choline acetyltransferase activity and small amounts of acetylcholine were also detected. Positive ChAT-immunoreactivity was demonstrated in situ in endothelial cells of the human umbilical cord. In addition, in experiments with confocal lase…

LipopolysaccharidesNicotinePathologymedicine.medical_specialtyEndotheliumPhysostigmineeducationHuman skinBiologyImmunofluorescenceGeneral Biochemistry Genetics and Molecular BiologyCell LineCholine O-Acetyltransferasemental disordersTumor Cells CulturedmedicineHumansNicotinic AgonistsGeneral Pharmacology Toxicology and PharmaceuticsChromatography High Pressure LiquidMicroscopy Confocalmedicine.diagnostic_testCell adhesion moleculeAntibodies MonoclonalGeneral MedicineImmunohistochemistryCholine acetyltransferaseAcetylcholinehumanitiesCell biologymedicine.anatomical_structureNicotinic agonistnervous systemCell cultureCholinesterase InhibitorsEndothelium VascularCell Adhesion MoleculesAcetylcholineSignal Transductionmedicine.drugLife Sciences
researchProduct

Colocalization but differential regulation of neuronal NO synthase and nicotinic acetylcholine receptor in C2C12 myotubes.

2003

In mammalian skeletal muscle, neuronal-type nitric oxide synthase (nNOS) is found to be enriched at neuromuscular endplates. Here we demonstrate the colocalization of the nicotinic acetylcholine receptor (nAChR, stained with α-bungarotoxin) and nNOS (stained with a specific antibody) in murine C2C12myotubes. However, coimmunoprecipitation experiments demonstrated no evidence for a direct protein-protein association between the nAChR and nNOS in C2C12myotubes. An antibody to the α1-subunit of the nAChR did not coprecipitate nNOS, and an nNOS-specific antibody did not precipitate the α1-subunit of the nAChR. Treatment of mice with bacterial LPS downregulated the expression of nNOS in skeletal…

LipopolysaccharidesPhysiologyMuscle Fibers SkeletalNitric Oxide Synthase Type IReceptors NicotinicCell LineInterferon-gammaMicemedicineAnimalsProtein IsoformsTissue DistributionRNA MessengerMuscle SkeletalMice Inbred C3HbiologyMyogenesisSkeletal muscleColocalizationCell BiologyMolecular biologyNitric oxide synthaseNicotinic acetylcholine receptormedicine.anatomical_structureNicotinic agonistnervous systembiology.proteinNitric Oxide SynthaseC2C12Acetylcholinemedicine.drugAmerican journal of physiology. Cell physiology
researchProduct

Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity.

2012

The functional significance of adult neural stem and progenitor cells in hippocampal-dependent learning and memory has been well documented. Although adult neural stem and progenitor cells in the subventricular zone are known to migrate to, maintain and reorganize the olfactory bulb, it is less clear whether they are functionally required for other processes. Using a conditional transgenic mouse model, selective ablation of adult neural stem and progenitor cells in the subventricular zone induced a dramatic increase in morbidity and mortality of central nervous system disorders characterized by excitotoxicity-induced cell death accompanied by reactive inflammation, such as 4-aminopyridine-i…

LipopolysaccharidesPolyunsaturated AlkamidesSubventricular zoneGlutamic AcidMice TransgenicArachidonic AcidsBiologyAmidohydrolasesGlutamatergicMiceNeural Stem CellsLateral VentriclesmedicineAnimalsDronabinolProgenitor cell4-Aminopyridineneurogenesis; ischaemia; neural stem cells; excitotoxicity; endocannabinoidsGanciclovirEpilepsyStem CellsNeurogenesisExcitatory Postsynaptic PotentialsNeural stem cellCorpus StriatumNeuroepithelial cellMice Inbred C57BLStrokeneurogenesisDisease Models Animalmedicine.anatomical_structureNeuroprotective AgentsBenzamidesSettore MED/26 - NeurologiaNeurology (clinical)ischaemiaCarbamatesStem cellNeuroscienceexcitotoxicityExcitatory Amino Acid AntagonistsAdult stem cellEndocannabinoidsBrain : a journal of neurology
researchProduct

Tiratricol neutralizes bacterial endotoxins and reduces lipopolysaccharide-induced TNF-alpha production in the cell.

2008

Contains fulltext : 70610.pdf (Publisher’s version ) (Closed access) The screening of a commercially available library of compounds has proved a successful strategy for the identification of a lead compound in a drug discovery programme. Here, we analysed 880 off-patent drugs, which initially comprised the Prestwick Chemical library, as sources of bacterial endotoxin neutralizers. We identified 3,3',5-triiodo-thyroacetic acid (tiratricol) as a non-antibacterial compound that neutralizes the toxic lipopolysaccharide.

LipopolysaccharidesendotoxinLipopolysaccharideCelllipopolysaccharide-antagonistsBiology:Enginyeria dels materials [Àrees temàtiques de la UPC]BiochemistryCell LineChemical libraryMicrobiologyLipid ASepsissepsisMiceStructure-Activity Relationshipchemistry.chemical_compoundtumour necrosis factor-alphaDrug DiscoveryEscherichia colimedicineAnimalsDrugs--Designlipid APharmacologyTriiodothyroacetic acidMedicaments -- DissenyTumor Necrosis Factor-alphaDrug discoveryOrganic Chemistrylipopolysaccharidetumour necrosis factor-amedicine.diseaseAnti-Bacterial AgentsEndotoxinsmedicine.anatomical_structurechemistryTriiodothyronineMolecular Medicineseptic shockLead compoundImmunity infection and tissue repair [NCMLS 1]
researchProduct

Trench-parallel spreading ridge subduction and its consequences for the geological evolution of the overriding plate: Insights from analogue models a…

2018

A series of 3-D asthenospheric-scale analogue models have been conducted in the laboratory in order to simulate the arrival of a spreading ridge at the trench and understand its effect on plate kinematics, slab geometry, and on the deformation of the overriding plate. These models are made of a two-layered linearly viscous system simulating the lithosphere and asthenosphere. We reproduce the progressive decrease in thickness of the oceanic lithosphere at the trench. We measure plate kinematics, slab geometry and upper plate deformation. Our experiments reveal that the subduction of a thinning plate beneath a freely moving overriding continent favors a decrease of the subduction velocity and…

Lithosphere010504 meteorology & atmospheric sciences010502 geochemistry & geophysicsGeociencias multidisciplinaria01 natural sciencesCiencias de la Tierra y relacionadas con el Medio AmbienteSUBDUCTIONAnalogue modelingLithosphereAsthenospherePatagoniaOceanic ridgeSouthernmost AndesANALOGUE MODELING0105 earth and related environmental sciencesEarth-Surface Processes[SDU.STU.TE]Sciences of the Universe [physics]/Earth Sciences/TectonicsgeographySLAB PULL FORCEgeography.geographical_feature_categoryVolcanic arcSubductionMid-ocean ridge[ SDU.STU.TE ] Sciences of the Universe [physics]/Earth Sciences/TectonicsSubductionLITHOSPHEREPATAGONIAGeophysicsRidgeTrenchSlabSOUTHERNMOST ANDESSlab pull forceOCEANIC RIDGEGeologySeismologyCIENCIAS NATURALES Y EXACTAS
researchProduct

Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis

2013

Summary Background Propranolol is recommended for prophylaxis of variceal bleeding in cirrhosis. Carvedilol is a nonselective beta-blocker with a mild anti-alfa-1-adrenergic activity. Several studies have compared carvedilol and propranolol, yielding inconsistent results. Aim To perform a systematic review and meta-analysis of the randomised clinical trials comparing carvedilol with propranolol for hepatic vein pressure gradient reduction. Methods Studies were searched on the MEDLINE, EMBASE and Cochrane library databases up to November 2013. The weighted mean difference in percent hepatic vein pressure gradient reduction and the relative risk of failure to achieve a hemodynamic response (r…

Liver CirrhosisCirrhosisAdrenergic beta-AntagonistsCarbazolesPropranololHepatic VeinsCochrane LibraryPropanolaminesHypertension PortalmedicineHumansPharmacology (medical)Adverse effectCarvedilolHepatologybusiness.industryHemodynamicsGastroenterologymedicine.diseasePropranololMeta-analysisAnesthesiaRelative riskPortal hypertensionCarvedilolbusinessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.

2013

BACKGROUND AND AIMS: Plasma levels of NT-pro-BNP, a natriuretic peptide precursor, are raised in the presence of fluid retention of cardiac origin and can be used as markers of cardiac dysfunction. Recent studies showed high levels of NT pro BNP in patients with cirrhosis. We assessed NT pro-BNP and other parameters of cardiac dysfunction in patients with cirrhosis, with or without ascites, in order to determine whether the behaviour of NT pro BNP is linked to the stage of liver disease or to secondary cardiac dysfunction. METHODS: Fifty eight consecutive hospitalized patients mostly with viral or NAFLD-related cirrhosis were studied. All underwent abdominal ultrasound and upper GI endoscop…

Liver CirrhosisMaleCirrhosisAnatomy and Physiologylcsh:MedicineCardiovascularCardiovascular SystemLiver diseaseAscitesNatriuretic Peptide BrainNatriuretic peptidePathologylcsh:ScienceMultidisciplinaryLiver DiseasesMiddle AgedHypertensioncardiovascular systemCardiologyMedicineFemalemedicine.symptomhormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologyResearch Articlemedicine.medical_specialtymedicine.drug_classGastroenterology and HepatologyCardiac dysfunctionDiagnostic MedicineInternal medicinemedicineHumanscardiovascular diseasesHeart Atriabusiness.industryAcute Cardiovascular Problemscirrhosislcsh:RCase-control studyPlasma levelsmedicine.diseasePeptide FragmentsEndocrinologyCase-Control Studieslcsh:QN terminal pro b type natriuretic peptidebusinesshuman activitiesBiomarkersGeneral Pathology
researchProduct

Potentially inappropriate use of furosemide in a very elderly population: An observational study

2017

International audience; ObjectiveLittle is known about furosemide prescription modalities in elderly people. We describe furosemide prescription in ambulatory elderly patients.MethodsAll patients aged over 80 years, affiliated to Mutualité Sociale Agricole de Bourgogne, a French regional health insurance plan, with a medical prescription delivered in March 2015, were retrospectively included.ResultsAmong 15 141 patients with a median age of 86 years, comprising 61.3% of women, 3937 patients (26%) had a prescription for furosemide. Severe heart failure was the most common chronic comorbidity (27.7%). Furosemide was considered a long-term therapy for almost all patients (98.7% with prescripti…

Liver CirrhosisMalePediatricsmedicine.medical_specialtyAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsInappropriate Prescribing[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology030204 cardiovascular system & hematologyDrug PrescriptionsNephropathy03 medical and health sciences0302 clinical medicineFurosemidemedicineHumans030212 general & internal medicineMedical prescriptionRenal Insufficiency ChronicDiureticsRetrospective StudiesAged 80 and overHeart Failurebusiness.industryAge FactorsFurosemideRetrospective cohort studyGeneral Medicinemedicine.diseaseComorbidityHeart failureAmbulatoryObservational studyFemalebusinessmedicine.drug
researchProduct

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

2018

Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in patients with decompensated cirrhosis. The human Albumin for the treatmeNt of aScites in patients With hEpatic ciRrhosis (ANSWER) study was designed to clarify this issue. Methods We did an investigator-initiated multicentre randomised, parallel, open-label, pragmatic trial in 33 academic and non-academic Italian hospitals. We randomly assigned patients with cirrhosis and uncomplicated ascites who were treated with anti-aldosteronic drugs (≥200 mg/day) and furosemide (≥25 mg/day) to receive either standard medical treatment (SMT) or SMT plus HA (40 g twice weekly for 2 weeks, and then 40 g weekly…

Liver CirrhosisMaleTime FactorsCirrhosisKaplan-Meier Estimatelaw.inventionascites0302 clinical medicineHepatorenal syndromeRandomized controlled trialFurosemidelawAscitesClinical endpointParacentesisDiureticsalbumin decompensated cirrhosiMineralocorticoid Receptor AntagonistsSettore MED/12 - GastroenterologiaMedicine (all)Hazard ratioGeneral MedicineMiddle AgedSurvival RateCirrhosis030220 oncology & carcinogenesisDrug Therapy CombinationFemale030211 gastroenterology & hepatologyQuality-Adjusted Life Yearsmedicine.symptomHyponatremiamedicine.medical_specialty03 medical and health sciencesAlbuminsInternal medicinemedicineHumansSurvival ratealbuminAgedbusiness.industrycirrhosis; albumin; ascitesmedicine.diseaseClinical trialalbumin cirrhosis ascites liver decompensationQuality of LifeHyperkalemiabusinessEsophagus Varices Portal Hypertension Varicosis
researchProduct